|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18 Pt 1
|
|
pubmed:dateCreated |
2004-9-27
|
|
pubmed:abstractText |
The small GTPase RhoA has been implicated in the regulation of cell morphology, motility, and transformation, but the role of RhoA protein in the carcinogenesis of gastric cancer remains unclear. In the present study, we have analyzed the expression status of the RhoA protein in human gastric cancer cells and tissues and investigated the possible involvement of RhoA in regulating the malignant phenotype of gastric cancer cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Agar,
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazolium Salts,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles,
http://linkedlifedata.com/resource/pubmed/chemical/rhoA GTP-Binding Protein,
http://linkedlifedata.com/resource/pubmed/chemical/thiazolyl blue
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6239-47
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15448013-Agar,
pubmed-meshheading:15448013-Animals,
pubmed-meshheading:15448013-Antibiotics, Antineoplastic,
pubmed-meshheading:15448013-Antimetabolites, Antineoplastic,
pubmed-meshheading:15448013-Antineoplastic Agents,
pubmed-meshheading:15448013-Blotting, Western,
pubmed-meshheading:15448013-Cell Cycle,
pubmed-meshheading:15448013-Cell Differentiation,
pubmed-meshheading:15448013-Cell Line, Transformed,
pubmed-meshheading:15448013-Cell Line, Tumor,
pubmed-meshheading:15448013-Cell Movement,
pubmed-meshheading:15448013-Cell Proliferation,
pubmed-meshheading:15448013-DNA,
pubmed-meshheading:15448013-Disease Progression,
pubmed-meshheading:15448013-Dose-Response Relationship, Drug,
pubmed-meshheading:15448013-Doxorubicin,
pubmed-meshheading:15448013-Epithelial Cells,
pubmed-meshheading:15448013-Flow Cytometry,
pubmed-meshheading:15448013-Fluorouracil,
pubmed-meshheading:15448013-Genes, Dominant,
pubmed-meshheading:15448013-Humans,
pubmed-meshheading:15448013-Immunohistochemistry,
pubmed-meshheading:15448013-Mice,
pubmed-meshheading:15448013-Mutation,
pubmed-meshheading:15448013-Neoplasm Invasiveness,
pubmed-meshheading:15448013-Neoplasm Metastasis,
pubmed-meshheading:15448013-Oligonucleotides,
pubmed-meshheading:15448013-Phenotype,
pubmed-meshheading:15448013-RNA, Small Interfering,
pubmed-meshheading:15448013-Stomach Neoplasms,
pubmed-meshheading:15448013-Tetrazolium Salts,
pubmed-meshheading:15448013-Thiazoles,
pubmed-meshheading:15448013-Time Factors,
pubmed-meshheading:15448013-Transfection,
pubmed-meshheading:15448013-Wound Healing,
pubmed-meshheading:15448013-rhoA GTP-Binding Protein
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
|
|
pubmed:affiliation |
Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, Peoples Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
